The present disclosure relates generally to medical fluid treatments and in particular to dialysis fluid treatments.
Due to various causes, a person's renal system can fail. Renal failure produces several physiological derangements. It is no longer possible to balance water and minerals or to excrete daily metabolic load. Toxic end products of metabolism, such as, urea, creatinine, uric acid and others, may accumulate in a patient's blood and tissue.
Reduced kidney function and, above all, kidney failure is treated with dialysis. Dialysis removes waste, toxins and excess water from the body that normal functioning kidneys would otherwise remove. Dialysis treatment for replacement of kidney functions is critical to many people because the treatment is lifesaving.
One type of kidney failure therapy is Hemodialysis (“HD”), which in general uses diffusion to remove waste products from a patient's blood. A diffusive gradient occurs across the semi-permeable dialyzer between the blood and an electrolyte solution called dialysate or dialysis fluid to cause diffusion.
Hemofiltration (“HF”) is an alternative renal replacement therapy that relies on a convective transport of toxins from the patient's blood. HF is accomplished by adding substitution or replacement fluid to the extracorporeal circuit during treatment. The substitution fluid and the fluid accumulated by the patient in between treatments is ultrafiltered over the course of the HF treatment, providing a convective transport mechanism that is particularly beneficial in removing middle and large molecules.
Hemodiafiltration (“HDF”) is a treatment modality that combines convective and diffusive clearances. HDF uses dialysis fluid flowing through a dialyzer, similar to standard hemodialysis, to provide diffusive clearance. In addition, substitution solution is provided directly to the extracorporeal circuit, providing convective clearance.
Most HD, HF, and HDF treatments occur in centers. A trend towards home hemodialysis (“HHD”) exists today in part because HHD can be performed daily, offering therapeutic benefits over in-center hemodialysis treatments, which occur typically bi- or tri-weekly. Studies have shown that more frequent treatments remove more toxins and waste products and render less interdialytic fluid overload than a patient receiving less frequent but perhaps longer treatments. A patient receiving more frequent treatments does not experience as much of a down cycle (swings in fluids and toxins) as does an in-center patient, who has built-up two or three days' worth of toxins prior to a treatment. In certain areas, the closest dialysis center can be many miles from the patient's home, causing door-to-door treatment time to consume a large portion of the day. Treatments in centers close to the patient's home may also consume a large portion of the patient's day. HHD can take place overnight or during the day while the patient relaxes, works or is otherwise productive.
Another type of kidney failure therapy is peritoneal dialysis (“PD”), which infuses a dialysis solution, also called dialysis fluid, into a patient's peritoneal chamber via a catheter. The dialysis fluid is in contact with the peritoneal membrane in the patient's peritoneal chamber. Waste, toxins and excess water pass from the patient's bloodstream, through the capillaries in the peritoneal membrane, and into the dialysis fluid due to diffusion and osmosis, i.e., an osmotic gradient occurs across the membrane. An osmotic agent in the PD dialysis fluid provides the osmotic gradient. Used or spent dialysis fluid is drained from the patient, removing waste, toxins and excess water from the patient. This cycle is repeated, e.g., multiple times.
There are various types of peritoneal dialysis therapies, including continuous ambulatory peritoneal dialysis (“CAPD”), automated peritoneal dialysis (“APD”), tidal flow dialysis and continuous flow peritoneal dialysis (“CFPD”). CAPD is a manual dialysis treatment. Here, the patient manually connects an implanted catheter to a drain to allow used or spent dialysis fluid to drain from the peritoneal chamber. The patient then switches fluid communication so that the patient catheter communicates with a bag of fresh dialysis fluid to infuse the fresh dialysis fluid through the catheter and into the patient. The patient disconnects the catheter from the fresh dialysis fluid bag and allows the dialysis fluid to dwell within the peritoneal chamber, wherein the transfer of waste, toxins and excess water takes place. After a dwell period, the patient repeats the manual dialysis procedure, for example, four times per day. Manual peritoneal dialysis requires a significant amount of time and effort from the patient, leaving ample room for improvement.
Automated peritoneal dialysis (“APD”) is similar to CAPD in that the dialysis treatment includes drain, fill and dwell cycles. APD machines, however, perform the cycles automatically, typically while the patient sleeps. APD machines free patients from having to manually perform the treatment cycles and from having to transport supplies during the day. APD machines connect fluidly to an implanted catheter, to a source or bag of fresh dialysis fluid and to a fluid drain. APD machines pump fresh dialysis fluid from a dialysis fluid source, through the catheter and into the patient's peritoneal chamber. APD machines also allow for the dialysis fluid to dwell within the chamber and for the transfer of waste, toxins and excess water to take place. The source may include multiple liters of dialysis fluid including several solution bags.
APD machines pump used or spent dialysate from the patient's peritoneal cavity, though the catheter, and to the drain. As with the manual process, several drain, fill and dwell cycles occur during dialysis. A “last fill” may occur at the end of the APD treatment. The last fill fluid may remain in the peritoneal chamber of the patient until the start of the next treatment, or may be manually emptied at some point during the day.
Known APD systems include a machine or cycler that accepts and actuates a pumping cassette having a hard part and a soft part that is deformable for performing pumping and valving operations. Sealing the fluid disposable cassette with a pneumatic path via a gasket to provide actuation has proven to be a potential field issue, which can delay treatment start time and affect use experience. Pneumatic cassette systems also produce acoustic noise, which may be a source of customer dissatisfaction.
For each of the above reasons, an improved APD machine is needed accordingly.
The present disclosure sets forth a streamlined automated peritoneal dialysis APD cycler and associated system that uses a micropump. The micropumps of the cyclers of the present disclosure may be made of stainless steel and/or lower cost polymers. In one implementation, the pump head that contacts the dialysis fluid is disposable and is made of plastic. The lower actuator part of the micropump that drives the pump head in a cyclical manner and is reusable and is made of metal or plastic. The pump heads have an internal mechanism that drives the fluid, such as a rotating rotor, vane, a cam driven piston, or a flexing diaphragm. Each of the possible internal pumping head mechanisms is driven by the lower, e.g., reusable part of the micropump.
In one embodiment, volumetric accuracy is derived from the pump itself. That is, each rotation of the rotor or vane, or each actuation of a piston or diaphragm, pumps a known quantity of fluid, so that the total volume of dialysis fluid pumped to or removed from the patient is the volume per stroke multiplied by the number of strokes. Certain rotating vane pumps suitable for the micropump APD cycler and associated system of the present disclosure are only accurate in one dimension.
Fresh dialysis fluid pumped by the micropump is heated in one embodiment via an inline heater, which may be a resistance plate heater, such as a clamshell heater into which a serpentine fluid pathway of the disposable set is placed. Other types of inline heating may be used alternatively or additionally, such as radiant heating or inductive heating. Batch heaters may further alternatively be employed.
The valves used with the micropump APD cycler in one embodiment are two- or three-way stopcock valves having a disposable portion that includes a stem that is rotated into multiple positions to direct fluid in a desired direction. The disposable stem fits onto a reusable actuator that rotates the stem to a desired position. In an alternative embodiment, electromechanical pinch valves may be used to occlude the lines leading to the micropump and pressure sensors. In a further alternative embodiment, cassette-based valves, such as pneumatic valves may be used.
The rotating positive displacement micropumps of the present disclosure, such as rotating rotor or vane pumps, produce pulsating inlet and outlet pressures in one embodiment, which may be uncomfortable to the patient. It is accordingly contemplated to place a pressure sensor, such as a pod pressure sensor, between the micropump and the patient to measure the positive pressure of fresh dialysis fluid pumped to the patient and the negative pressure of used dialysis fluid removed from the patient. The pod pressure sensor includes a pod having a flexible membrane or diaphragm that separates a dialysis fluid side of the pod from a pressure transmission fluid (e.g., air) side of the membrane. The membrane or diaphragm also serves a second purpose, namely, to dampen the pump's input and output pressure fluctuations.
A second pressure sensor or pod may be placed between the micropump and the fluid source or drain. The fluid source may be multiple bags of premixed dialysis fluid or an online fluid source that mixes dialysis fluid at the point of use.
Another solution contemplated for the system and methodology of the present disclosure for managing the pulsatile nature of the micropump is to employ flowrate profiles. The peritoneal dialysis treatment of the present disclosure includes the cyclical introduction and removal of dialysis fluid to and from the patient's peritoneal cavity. Excess pressure in either direction may cause patient discomfort. The present system and associated methodology however capitalize on the phenomenon that the patient is most susceptible to discomfort at the beginning and end of both patient fills and patient drains. During the middle of both the fills and drains, patient discomfort is less likely and/or less intense. It is accordingly contemplated to employ flowrate profiles that begin a patient fill or drain at a lower flowrate, which is maintained until a certain amount of fluid is delivered to or removed from the patient, e.g., the first ten percent of a total fill or drain volume, after which the flowrate is ramped up to full speed according to a desired acceleration curve, e.g., linear or sinusoidal. At a certain point near the end of the fill or drain, e.g., the last ten percent, the flowrate is ramped down to the lower flowrate according to a desired deceleration curve, e.g., linear or sinusoidal. The system and methodology of the present disclosure may employ the flowrate profiles alone or in combination with pressure dampeners or pod pressure sensors to address the pulsatile input and output of the micropumps.
The amount of used dialysis fluid or effluent that needs to be removed from the patient after a dwell period is not known exactly because it is not known how much ultrafiltration (patient water) has osmosed into the patient's peritoneal cavity during a subsequent dwell phase, and it is not known how much residual fluid remains in the patient's cavity prior to the previous patient fill. The micropump system and method are accordingly able to detect when the patient is empty or near empty in one embodiment, so that a patient drain via the micropump can be terminated. In one embodiment, the output of pressure sensor located between the patient and the micropump is monitored. If a negative inlet pressure to the micropump increases (becomes more negative), e.g., to a threshold negative pressure or at a threshold rate of change in pressure, the control unit of the micropump APD cycler determines that the patient is empty or near empty. The negative pressure increases when the patient reaches empty because the pores in the patient's indwelling catheter begin to become blocked and a higher pressure gradient is needed to maintain flow. When the negative pressure spike is detected, the control unit of the micropump APD cycler causes the micropump to stop, completing the drain. The cycler then transitions to fill the patient with new dialysis fluid.
Peritoneal dialysis is commonly performed while the patient is sleeping, during which the patient may shift or turn and consequently fold or kink the patient line, occluding flow. The micropump system and method of the present disclosure is accordingly configured to use the pressure sensor or pod located between the micropump and the patient to look for a rise in pressure (an increase in negative pressure for a drain and an increase in positive pressure for a fill). If the pressure rises to a certain point, or a certain rate of pressure increase is detected, the patient fill or drain is stopped, and an alarm is sounded.
In light of the disclosure set forth herein, and without limiting the disclosure in any way, in a first aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a peritoneal dialysis (“PD”) system includes: a cycler including a micropump actuator, a pressure transducer, and at least one valve actuator; a disposable set including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator, a pressure sensor configured to operably communicate with the pressure transducer, and at least one fluid valve portion or a portion of at least one fluid line for interfacing with the at least one valve actuator; and a control unit, wherein the disposable set is arranged to allow, and the control unit is programmed to operate the micropump actuator and the at least one valve actuator so that fresh and used dialysis fluid flows through the micropump head in a same direction.
In a second aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the micropump actuator and the micropump head are more accurate in the same direction than in a reverse direction.
In a third aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the micropump actuator includes a keyed driver and the micropump head includes a keyed recess sized and shaped for mating with the keyed driver of the micropump actuator.
In a fourth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the pressure sensor includes a fluid pressure chamber having a sealed diaphragm configured to fluctuate due to pressure variations, and wherein the cycler includes a transmission fluid chamber positioned and arranged to mate with the fluid pressure chamber when the disposable set is mounted to the cycler.
In a fifth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a transmission fluid line extends from the transmission fluid chamber to the pressure transducer.
In a sixth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the pressure sensor includes a fluid pressure chamber having a sealed diaphragm configured to fluctuate due to pressure variations, and a transmission fluid chamber sealed to the fluid pressure chamber.
In a seventh aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the pressure sensor interfaces with the pressure transducer via a transmission fluid line placed in fluid communication with the transmission fluid chamber.
In an eighth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, at least one fluid valve portion includes a rotating stem and the at least one valve actuator is configured to rotate the rotating stem.
In a ninth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, at least one valve actuator is a pinch valve positioned and arranged to occlude the portion of at least one fluid line when the disposable set is mounted to the cycler.
In a tenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the disposable set includes an inline fluid heating pathway or a batch heater container, and the cycler includes an inline fluid heater or batch fluid heater positioned and arranged to heat the inline fluid heating pathway or the batch heater container, respectively, when the disposable set is mounted to the cycler.
In an eleventh aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the disposable set being arranged to allow fresh and used dialysis fluid to flow through the micropump head in a same direction includes disposing both a patient line and a drain line of the disposable set, at least during a patient fill phase, downstream of the micropump head.
In a twelfth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a peritoneal dialysis (“PD”) system includes: a cycler including a micropump actuator, and at least one valve actuator; a disposable set including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator, and at least one fluid valve portion or a portion of at least one fluid line for interfacing with the at least one valve actuator; and a control unit programmed to operate the micropump actuator so that at least one of fresh or used dialysis fluid flows at a lower flowrate at a beginning of at least one of a patient fill or a patient drain, respectively, than during a middle portion of the at least one of the patient fill or the patient drain.
In a thirteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the control unit is further programmed to operate the micropump actuator so that the at least one of fresh or used dialysis fluid flows at a lower flowrate at an end of the at least one of the patient fill or the patient drain, respectively, than during a middle portion of the at least one of the patient fill or the patient drain.
In a fourteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the disposable set further includes at least one pressure sensor positioned and arranged to dampen pressure fluctuations of fresh or used dialysis fluid flowing between the micropump head and a patient line.
In a fifteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a peritoneal dialysis (“PD”) system includes: a cycler including a micropump actuator, and a pressure transducer; a disposable set including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator, and a pressure sensor configured to operably communicate with the pressure transducer; and a control unit programmed to monitor a negative pressure from the pressure transducer during a patient drain in which the micropump actuator actuates the micropump head to remove used dialysis fluid from a patient, and wherein if the sensed negative pressure increases to a predefined extent, the control unit ends the patient drain.
In a sixteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the predefined extent includes (i) a threshold value, (ii) a threshold rate of change of negative pressure, or (iii) a combination of (i) and (ii).
In a seventeenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a peritoneal dialysis (“PD”) system includes: a cycler including a micropump actuator, and a pressure transducer; a disposable set including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator, and a pressure sensor configured to operably communicate with the pressure transducer; and a control unit programmed to monitor a negative pressure from the pressure transducer and a drain flowrate during a patient drain in which the micropump actuator actuates the micropump head to remove used dialysis fluid from a patient, and wherein if the sensed negative pressure increases to a first predefined extent and/or if the drain flowrate falls to a second predefined extent, the control unit determines that a drain occlusion has occurred.
In an eighteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the first predefined extent includes (i) a threshold value, (ii) a threshold rate of change of negative pressure, or (iii) a combination of (i) and (ii).
In a nineteenth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the second predefined extent includes (i) a threshold value, (ii) a threshold rate of change of flowrate, (iii) a combination of (i) and (ii), or (iv) a combination of (i), (ii) or (iii) with an output from a flowrate sensor.
In a twentieth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the control unit upon determining that the drain occlusion has occurred causes an instruction to be provided for clearing the occlusion.
In a twenty-first aspect of the present disclosure, which may be combined with any of other aspect discussed herein, a peritoneal dialysis (“PD”) system includes: a cycler including a micropump actuator, and a pressure transducer; a disposable set including a micropump head sized and shaped for mating with and being cyclically driven by the micropump actuator, and a pressure sensor configured to operably communicate with the pressure transducer; and a control unit programmed to monitor a positive pressure from the pressure transducer and a fill flowrate during a patient fill in which the micropump actuator actuates the micropump head to deliver fresh dialysis fluid to a patient, and wherein if the sensed positive pressure increases to a first predefined extent and/or if the fill flowrate falls to a second predefined extent, the control unit determines that a fill occlusion has occurred.
In a twenty-second aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the first predefined extent includes (i) a threshold value, (ii) a threshold rate of change of positive pressure, or (iii) a combination of (i) and (ii).
In a twenty-third aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the second predefined extent includes (i) a threshold value, (ii) a threshold rate of change of flowrate, (iii) a combination of (i) and (ii), or (iv) a combination of (i), (ii) or (iii) with an output from a flowrate sensor.
In a twenty-fourth aspect of the present disclosure, which may be combined with any of other aspect discussed herein, the control unit upon determining that the fill occlusion has occurred causes an instruction to be provided for clearing the occlusion.
In a twenty-fifth aspect, any of the features, functionality and alternatives described in connection with any one or more of
It is accordingly an advantage of the present disclosure to provide a micropump driven APD system, which is portable to ultra-portable (e.g., wearable) and compact.
It is another advantage of the present disclosure to provide a micropump driven APD system, wherein the micropump is at least partially reusable.
It is a further advantage of the present disclosure to provide a micropump driven APD system, which eliminates certain sealing issues present in known APD systems.
It is yet a further advantage of the present disclosure to provide a micropump driven APD system, which eliminates bulky pneumatic equipment associated with certain APD systems.
It is yet another advantage of the present disclosure to provide a micropump driven APD system, which manages peritoneal dialysis fluid flow so as to be within safe and comfortable patient pressure limits.
It is still another advantage of the present disclosure to provide a micropump driven APD system, which may reduce time to detect a patient empty condition and thus overall treatment time.
It is still a further advantage of the present disclosure to provide a micropump driven APD system, which may reduce patient exposure time to lower pressure.
Further still, it is an advantage of the present disclosure to provide a micropump driven APD system that can maintain flowrates under partial occlusion and thereby maintain or improve treatment time as compared with other APD systems.
Moreover, it is an advantage of the present disclosure to provide a portable APD system, wherein solution bag size may be reduced for treatment on the go.
Additional features and advantages are described in, and will be apparent from, the following Detailed Description and the Figures. The features and advantages described herein are not all-inclusive and, in particular, many additional features and advantages will be apparent to one of ordinary skill in the art in view of the figures and description. Also, any particular embodiment does not have to have all of the advantages listed herein and it is expressly contemplated to claim individual advantageous embodiments separately. Moreover, it should be noted that the language used in the specification has been selected principally for readability and instructional purposes, and not to limit the scope of the inventive subject matter.
Referring now to the drawings and in particular to
In the illustrated embodiment, disposable set 100a includes an inline fluid heating pathway 140. Inline fluid heating pathway 140 in the illustrated embodiment is located fluidly between first and second disposable, pressure sensors 102a and 102b and valve portions 120b and 130. Suitable materials for any of disposable set 100a, including any of pressure sensors 102a and 102b, fluid-contacting micropump head 110, fluid-contacting stopcock valve portions 120a, 120b and 130, inline fluid heating pathway 140 and any associated tubing include polyvinyl chloride (“PVC”), polyethylene (“PE”), polyurethane (“PU”), polycarbonate or other non-PVC material.
Disposable set 100a is illustrated from the bottom to show how different disposable components interact with their corresponding actuators. The underside of fluid-contacting micropump head 110 is illustrated in more detail in connection with
The holding force maintains membrane so as to be in contact with a rotor 118 over a full revolution and for each revolution. Rotor 118 includes an elliptical or oblong fluid contacting driver 118a that moves fresh or used dialysis fluid from inlet port 112a to outlet port 112b. Rotor 118 also includes or defines a keyed recess 118b, which in the illustrated embodiment has the shape of a star. Keyed recess 118b fits onto a reusable micropump actuator, which is located within a cycler or machine of the present disclosure. The micropump actuator is operated under control of a control unit to spin at a desired or preprogrammed rate. The rate is variable in certain embodiments for reasons discussed herein.
In an embodiment, fluid-contacting micropump head 110 may be operated in two directions, such that the roles of inlet port 112a and outlet port 112b may be reversed. Certain types of micropumps are only accurate in one direction, so that at least some of the flowpaths discussed below only route fresh or used dialysis fluid in one direction through micropump head 110, at least where accuracy is required. Regarding accuracy, in
Further information regarding the micropump of
The micropump of
In particular,
In the illustrated embodiment, tubing attached to port 122a of three-way fluid-contacting stopcock valve portion 120a extends to a last fill container or bag, which may for example contain icodextrin, which has a different formulation than the peritoneal dialysis solution used in prior fills. Tubing attached to port 122c of three-way fluid-contacting stopcock valve portion 120a extends to a supply container or bag of peritoneal dialysis solution used in the prior fills. Tubing attached to port 122c of three-way fluid-contacting stopcock valve portion 120b extends to the patient. Tubing attached to port 122b of three-way fluid-contacting stopcock valve portion 120b extends to an inline heater outlet lines. Tubing attached to port 132c of three-way fluid-contacting stopcock valve portion 130 extends to the inline heater inlet line. Tubing attached to port 132b of three-way fluid-contacting stopcock valve portion 130a extends to a drain container or bag or to a house drain.
Lids 26a and 26b open to allow disposable set 100a to be translated down into APD cycler 20 so that keyed recess 118b of rotor 118 of fluid-contacting micropump head 110 fits onto a mating keyed driver of reusable micropump actuator 30. Reusable micropump actuator 30 in the illustrated embodiment is driven by a motor 32 under control of control unit 50, such as a stepper motor, which may be fitted with an encoder that outputs to the control unit.
In
In
In
Referring now to
In
For lower supply and last fill lines 152c and 152d, micropump head 110 is run in reverse to pull fresh dialysis fluid from a supply container connected to lines 152c and 152d (one at a time) to fill empty supply container or bags connected to lines 152a or 152b, after which fresh dialysis fluid is pumped to the patient via serpentine heating pathway 140 via patient line 154. This procedure ensures that the accurate pump direction is used to deliver fluid to patient via the inline heater regardless of which supply container or bag is used. Container or bags 152a and 152b are emptied to drain prior to bags 152c and 152d being needed for treatment. Reverse pumping for micropump head 110, although not accurate across flow and pressure boundary conditions, is nevertheless available for pumping in situations in which flow and pressure accuracy is not important. When pumping in the accurate direction using micropump head 110, a signal from outlet pressure sensor 102b to control unit 50 is used as feedback to ensure that fresh dialysis fluid positive pressure to the patient is at or within a limit, e.g., 3 psig out of a range of 1.5 psig to 9 psig.
In
It should be appreciated that for both patient fills and drains in the embodiment of system 10 in connection with
Referring now to
Disposable set 100b includes fluid-contacting micropump head 110 and first and second disposable, pressure sensors or pods 102a and 102b, including all of their structure, functionality and alternatives described herein. Pressure sensor 102a is again an inlet pressure sensor that monitors a negative incoming fresh dialysis fluid pressure from supply line 152a (connected fluidly to a supply container), last fill line 152d (connected fluidly to a last fill container) and a negative incoming used dialysis fluid pressure from a used fluid patient line 154u. Pressure sensor 102b is again an outlet pressure sensor that monitors a positive outgoing fresh dialysis fluid pressure through fresh fluid patient line 154f and a positive outgoing used dialysis fluid pressure through drain line 158.
In the illustrated embodiment, disposable set 100b provides a Y- or T-connector 160 that fluidly merges fresh patient line 154f and used patient line 154u into a common patient line 154 that leads to the patient's catheter set. Inline fluid heating pathway 140 is illustrated in block form as being located along fresh patient line 154f. Pinch valve 60a selectively opens or occludes supply line 152a. Pinch valve 60b selectively opens or occludes last fill line 152d. Pinch valve 60c selectively opens or occludes used fluid patient line 154u. Pinch valve 60d selectively opens or occludes drain line 158. Pinch valve 60e selectively opens or occludes fresh fluid patient line 154f upstream from fluid heating pathway 140. Pinch valve 60f selectively opens or occludes fresh fluid patient line 154f downstream from fluid heating pathway 140. Pinch valve 60g selectively opens or occludes common patient line 154.
Fluid-contacting micropump head 110 communicates fluidly with (i) the outlet from pressure sensor 102a via pump inlet line 162 and (ii) the inlet to pressure sensor 102b via pump outlet line 164. In
In
It should be appreciated that for both patient fills and drains in the embodiment of system 10 in connection with
Referring now to
Fluid-contacting micropump head 150 is located between first and second disposable, pressure sensors or pods 102a and 102b. Pressure sensor 102a is located fluidly between first and second three-way disposable, fluid-contacting stopcock valve portions 120a and 120b. Pressure sensor 102b is in fluid communication with a third three-way disposable, fluid-contacting stopcock valve portion 120c. Three-way valve portion 120a provides alternative fluid communication with the patient via patient line 154 or a first supply line 152a leading to a first supply container, e.g., bag. Three-way valve portion 120b provides alternative fluid communication with a second supply line 152b leading to a second supply container, e.g., bag, or a last fill line 152d, which is connected to a last fill dialysis fluid supply container (e.g., bag, last fill for extended dwell). Three-way valve portion 120c provides alternative fluid communication with heater bag 170 via a heater bag line 172 or drain line 158 leading to a drain container (e.g., bag) or house drain (e.g., toilet or bathtub).
Using disposable set 100c, control unit 50 of system 10 for a patient fill manipulates three-way valve portions 120a and 120b and actuates micropump head 150 so as to draw fresh dialysis fluid or last fill fluid from its respective source and push same to heater bag 170, where a resistive plate and/or radiant or other heater heats the batch of fresh dialysis fluid to body temperature, e.g., 37° C. Once heated, control unit 50 manipulates three-way valve portions 120a to 120c and actuates micropump head 150 so as to draw fresh, heated dialysis fluid from heater bag 170 and push same in the reverse direction to the patient via patient line 154. While it is beneficial to be accurate in both directions so as not to overfill or underfill heater bag 170, it is more important to be accurate pumping in the second direction to provide a prescribed fill volume to the patient.
During a patient dwell phase using disposable set 100c, control unit 50 causes a second batch of dialysis fluid to be heated in heater bag 170 via the sequence described above.
Using disposable set 100c, control unit 50 of system 10 for a patient drain manipulates three-way valve portions 120a and 120c and actuates micropump head 150 so as to draw used dialysis fluid from the patient via patient line 154 and push same to a drain container or house drain via drain line 158. It is important in the patient drain to be accurate to know how much effluent has been removed from the patient, so that an accurate amount of ultrafiltration (“UF”) removed from the patient is calculated by control unit subtracting the fill volume from the drain volume.
One possible way to use a micropump that is accurate in one direction with batch heating is to move drain line 158 and the drain to one of supply lines 152a or 152b and make the remaining supply container larger. The now empty port of three-way valve portions 120c is then connected to an empty sample container, which initially receives a patient drain from a non-accurate flow direction. Next, control unit 50 causes a second batch of heated, fresh dialysis fluid to be pumped in an accurate direction to the patient via patient line 154. After the second patient fill, control unit 50 causes the drain fluid to be pumped from the sample container in the accurate direction to drain via drain line 158. After the removal of effluent to drain, control unit 50 causes a next patient fill volume, e.g., last fill volume, to be pumped to heater bag 170 for a subsequent patient fill.
Referring now to
In
Regarding the inline heating of system 10, preliminary data have shown positive results. The data demonstrates the flow profile from micropump head 110 or 150 in combination with the dampening discussed herein is suitable, e.g., continuous enough, to be used with inline heating and to deliver fresh, heated dialysis fluid to the patient in an accurate manner.
In
It should be appreciated that for both patient fills and drains in the embodiment of system 10 in connection with
As discussed above and as illustrated below in connection with
It is accordingly contemplated to program control unit 50 to store flowrate profiles that cause the micropump having fluid portion 110 or 150 to begin a patient fill or drain at a lower flowrate until a certain amount of fresh or used dialysis fluid is delivered to or removed from the patient, e.g., the first ten percent of a total fill or drain volume. After the initial defined amount of fresh or used dialysis fluid is delivered or removed, control unit 50 running the appropriate profile causes the micropump having fluid portion 110 or 150 to ramp the flowrate up to full speed according to a desired acceleration curve, e.g., linear or sinusoidal. At a certain point near the end of the fill or drain, e.g., the last ten percent, control unit 50 running the appropriate profile causes the micropump having fluid portion 110 or 150 to ramp the flowrate down to the same or different lower flowrate according to a desired deceleration curve, e.g., linear or sinusoidal. The system and methodology of the present disclosure may employ the flowrate profiles alone or in combination with pressure dampeners or pressure sensors or pods 102a and 102b to address the pulsatile input and output nature of the micropumps of the present disclosure.
Referring now to
It should be noted that the treatment algorithm stored on control unit 50 may employ checks for occlusion before a patient drain is considered complete or that the patient is considered to be empty enough to stop the current drain phase.
Referring now to
It should be noted that since the embodiments illustrated herein do not directly measure flowrate other than expected stroke volume discussed herein, pressure decay is the indicator for negative pressure drain occlusion. It is contemplated in alternative embodiments to add one or more flow sensor outputting to control unit 50 in any of the implementations discussed hereon. Here, the flowrate sensor output may be used alternatively to or additionally with the pressure decay the indicator for negative pressure drain occlusion just described.
Referring now to
As illustrated above, micropump system 10 provides certain advantages regarding empty and occlusion detection. Empty and occlusion detection based on pressure decay or rise as described herein provides quick results. Partial occlusions, which may result in slower flowrates in other types of APD systems, do not affect micropump system 10 similarly, because the micropump system is able to maintain required flowrates even with the partial occlusion due to its higher pressure vs accuracy capability, thereby maintaining a prescribed treatment time or improving treatment time compared to other types of systems.
Regarding the dampening effects of pressure pods 102a and 102b discussed herein,
It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. For example, instead of providing lids 26a and 26b that open to allow disposable set 100a to be translated down into APD cycler 20, disposable set 100a could instead be loaded directly onto the top of the cycler. Also, while stopcock and pinch valves have been illustrated, it is contemplated to alternatively provide cassette-based valves, such as pneumatic valves. Moreover, any of the three-way valves described herein may be replaced with multiple two-way valves. It is therefore intended that such changes and modifications be covered by the appended claims.
Number | Date | Country | Kind |
---|---|---|---|
202041033187 | Aug 2020 | IN | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/043614 | 7/29/2021 | WO |